Quick Takeaways
- Stuart Feldman filed SCHEDULE 13G for Mural Oncology plc Ordinary Shares (MURA).
- Disclosed ownership: 4.4%.
- Date of event: 16 Apr 2025.
Stuart Feldman - 16 Apr 2025 SCHEDULE 13G Report for Mural Oncology plc Ordinary Shares (MURA)
- Filing Manager
- Stuart Feldman
- Reporting Manager
- Stuart Feldman
- Security
- Mural Oncology plc Ordinary Shares
- Symbol
- MURA
- Shares outstanding
- 17,400,000 shares
- Disclosed Ownership
- 765,600 shares
- Ownership
- 4.4%
- Form type
- SCHEDULE 13G
- Filing time
- 14 May 2025, 17:13:45 UTC
- Date of event
- 16 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Stuart Feldman disclosed 4.4% ownership in Mural Oncology plc Ordinary Shares (MURA) on 16 Apr 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 May 2025, 17:13.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Hudson View Holdings LLC | 4.4% | 100 | 765,600 | 0 | /s/ Jeffrey Goldberg | Authorized Signatory | |
| Hudson View Capital LLC | 4.4% | 100 | 765,600 | 0 | /s/ Jeffrey Goldberg | Authorized Signatory | |
| Stuart Feldman | 4.4% | 765,600 | 765,600 | 0 | /s/ Joseph Brucchieri | Attorney-in-fact | |
| Matthew Barkoff | 1.1% | 191,400 | 191,400 | 0 | /s/ Matthew Barkoff | Self |